| Q56776859 | Q56776859 |
| Q70047114 | "Anti-Ia reactivity in sera from patients with chronic active hepatitis (CAH)" |
| Q51289629 | 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. |
| Q64934761 | A Monocentric Cohort of Obstetric Seronegative Anti-Phospholipid Syndrome. |
| Q68836895 | A calf thymus acid lysate improves clinical symptoms and T-cell defects in the early stages of HIV infection: second report |
| Q39955870 | A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis |
| Q33350227 | A new player in the antiphospholipid syndrome: the beta 2 glycoprotein I cofactor |
| Q45828136 | A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome |
| Q39983474 | Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis |
| Q60810867 | Activation-Induced Cytidine Deaminase Expression in Follicular Dendritic Cell Networks and Interfollicular Large B Cells Supports Functionality of Ectopic Lymphoid Neogenesis in Autoimmune Sialoadenitis and MALT Lymphoma in Sjogren's Syndrome |
| Q39366004 | Adult-onset Still disease: a rare disorder with a potentially fatal outcome |
| Q64092947 | Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome |
| Q68094523 | Amaurosis fugax and antiphospholipid antibodies |
| Q37872396 | An overview on the genetic of rheumatoid arthritis: a never-ending story |
| Q47605442 | Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE). |
| Q28575717 | Anti-beta 2-glycoprotein I antibodies bind to central nervous system |
| Q72345769 | Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? |
| Q55365455 | Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus. |
| Q50804382 | Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor. |
| Q73561023 | Anti-carbonic anhydrase II antibodies in systemic sclerosis: association with lung involvement |
| Q72549945 | Anti-cardiolipin antibodies in HIV infection are true antiphospholipids not associated with antiphospholipid syndrome |
| Q33251075 | Anti-endothelial antibodies and neuropsychiatric systemic lupus erythematosus |
| Q39196176 | Anti-endothelial cell antibodies in rheumatic heart disease |
| Q28218219 | Anti-inflammatory and immunosuppressive drugs and reproduction |
| Q38953620 | Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features |
| Q77500048 | Anti-prothrombin but not "pure" anti-cardiolipin antibodies are associated with the clinical features of the antiphospholipid antibody syndrome |
| Q38916583 | Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab |
| Q35551832 | Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13. |
| Q71553040 | Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies |
| Q58421669 | Anticardiolipin antibodies and prostacyclin synthesis |
| Q44124180 | Anticardiolipin antibodies possess anticoagulant activity which is blocked by a monoclonal antibody against a cross reacting idiotype of antiphospholipid antibodies |
| Q24514516 | Anticardiolipin antibodies: occurrence in Behçet's syndrome |
| Q42692933 | Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems |
| Q58421677 | Anticoagulant activity of anticardiolipin antibodies |
| Q58421159 | Antioxidant treatment decreases the titer of circulating anticardiolipin antibodies: Comment on the article by Sambo et al |
| Q48114647 | Antiphospholipid antibodies and cerebral artery dissection: two frequent causes of brain ischemia in young adults |
| Q35630097 | Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis |
| Q72549144 | Appearance of anti-acetylcholine receptor antibodies coincident with onset of myasthenic weakness in patient with systemic lupus erythematosus |
| Q28485323 | Application of a stochastic modeling to assess the evolution of tuberculous and non-tuberculous mycobacterial infection in patients treated with tumor necrosis factor inhibitors |
| Q51362529 | Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients. |
| Q61848543 | Association of circulating CXCL10 and CXCL11 with systemic sclerosis |
| Q52570508 | Autoantibodies and common idiotypes in men and women with sperm antibodies. |
| Q30481778 | Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis |
| Q36958337 | Autoantibody production in anti-TNF-alpha-treated patients |
| Q24805595 | Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies |
| Q35557370 | Autoimmune aspects of cytokine and anticytokine therapies |
| Q43049484 | Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis |
| Q86088550 | Autoinflammation and autoimmunity: pathogenic, clinical, diagnostic and therapeutic aspects |
| Q57175476 | Autophagy and Rheumatoid Arthritis: Current Knowledges and Future Perspectives |
| Q37012550 | B cells in SLE: different biological drugs for different pathogenic mechanisms |
| Q44461543 | Beta-2-glycoprotein I expression on monocytes is increased in anti-phospholipid antibody syndrome and correlates with tissue factor expression |
| Q40975353 | Beta2-glycoprotein I (beta2-GPI) mRNA is expressed by several cell types involved in anti-phospholipid syndrome-related tissue damage |
| Q36984665 | Biological and clinical effects of anti-TNFalpha treatment |
| Q68441076 | Biopsy of the minor salivary glands in Sjögren's syndrome |
| Q44425363 | Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study |
| Q35659545 | CD8+ T Cells Specific to Apoptosis-Associated Antigens Predict the Response to Tumor Necrosis Factor Inhibitor Therapy in Rheumatoid Arthritis |
| Q60810847 | CXCL13, CCL21, and CXCL12 Expression in Salivary Glands of Patients with Sjogren's Syndrome and MALT Lymphoma: Association with Reactive and Malignant Areas of Lymphoid Organization |
| Q73938362 | Cardiac involvement in Behçet's disease |
| Q73152543 | Cardiac involvement in patients with Wegener's granulomatosis |
| Q73223383 | Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipids antibodies |
| Q38064250 | Cartilage as a target of autoimmunity: a thin layer |
| Q72155864 | Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate |
| Q55305483 | Changes in T cell effector functions over an 8-year period with TNF antagonists in patients with chronic inflammatory rheumatic diseases. |
| Q57231940 | Characterization of the anticollagen antibody response in a new model of chronic polyarthritis |
| Q72503977 | Chronic fatigue syndrome: what factors trigger it off? |
| Q55065823 | Chronic fatigue: a peculiar evolution of eosinophilia myalgia syndrome following treatment with L-tryptophan in four Italian adolescents. |
| Q77647612 | Churg-Strauss syndrome during pregnancy after steroid withdrawal |
| Q39824563 | Circulating Reg1α proteins and autoantibodies to Reg1α proteins as biomarkers of β-cell regeneration and damage in type 1 diabetes |
| Q72101725 | Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies |
| Q70433626 | Circulating immune complexes in sera of patients infected with Echinococcus granulosus |
| Q38338006 | Citrullination and autoimmunity |
| Q68835769 | Class II MHC antigen expression on epithelial cells of salivary glands from patients with Sjögren's syndrome |
| Q68801877 | Clinical improvement and partial correction of the T cell defects of acquired immunodeficiency syndrome (AIDS) and lymphoadenopathy syndrome (LAS) by a calf thymus acid lysate |
| Q69637476 | Clinical serological correlations in the evaluation of Sjögren's syndrome |
| Q40297017 | Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study |
| Q58421342 | Coexistence of Anti-Phospholipid Antibodies and Endothelial Perturbation in Systemic Lupus Erythematosus Patients With Ongoing Prothrombotic State |
| Q48292647 | Complementary treatment in fibromyalgia: combination of somatic and abdominal acupuncture. |
| Q37744201 | Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. |
| Q28211979 | Cyclophosphamide and immunoadsorption apheresis treatment of lupus nephritis nonresponsive to drug therapy alone |
| Q70632768 | Cyclosporin A in the treatment of relapsing polychondritis with severe recurrent eye involvement |
| Q35553375 | Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement |
| Q77653105 | Decreased immunoreactive beta-endorphin in mononuclear leucocytes from patients with chronic fatigue syndrome |
| Q73783297 | Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer |
| Q72676759 | Detection of anti-phospholipid and anti-DNA antibodies and their idiotypes in newborns of mothers with anti-phospholipid syndrome and SLE |
| Q43999720 | Detection of antiphospholipid antibodies by immunostaining on thin layer chromatography plates. |
| Q52902626 | Determination of antibodies to extractable nuclear antigens by commercial kits: a multicenter study. |
| Q38262100 | Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus |
| Q50639182 | Diagnosis of catastrophic anti-phospholipid syndrome in a patient tested negative for conventional tests. |
| Q50916283 | Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. |
| Q58421550 | Dilute aPTT prolongation by antiphospholipid antibodies in patients with liver cirrhosis |
| Q53080250 | Discovering the pathogenesis of autoimmune diseases at the 9th International Congress of Autoimmunity, Nice, France, 2014. |
| Q57650031 | Distribution of two common idiotypes of anticardiolipin antibodies in sera of patients with primary antiphospholipid syndrome, systemic lupus erythematosus and monoclonal gammopathies |
| Q37950727 | Does seronegative antiphospholipid syndrome really exist? |
| Q26778262 | EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide |
| Q34110066 | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs |
| Q37816066 | EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases |
| Q51736133 | Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis. |
| Q38266321 | Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature review |
| Q37871150 | Emerging role for NK cells in the pathogenesis of inflammatory arthropathies |
| Q58421321 | Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies |
| Q58421151 | Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment |
| Q61685040 | Eosinophil cationic protein serum levels and allergy in chronic fatigue syndrome |
| Q61883928 | Epitope Specificity of Anti-HIV Antibodies in Human and Murine Autoimmune Diseases |
| Q42337832 | Erratum to: Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients |
| Q37939700 | European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies |
| Q45375285 | Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment. |
| Q69869485 | Evaluation of T cell subsets in Behçet's syndrome using anti-T cell monoclonal antibodies |
| Q45717284 | Evaluation of degranulation and cytokine production in natural killer cells from spondyloarthritis patients at single-cell level |
| Q31139238 | Evaluation of the patient acceptable symptom state (PASS) in Italian patients affected by systemic lupus erythematosus: association with disease activity indices |
| Q58421167 | Evidence for anticoagulant activity and beta2-GPI accumulation in late endosomes of endothelial cells induced by anti-LBPA antibodies |
| Q45279700 | Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis |
| Q49116944 | Evidence of impaired sense of smell in hereditary angioedema |
| Q40639743 | Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and Thrombosis |
| Q50780156 | Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. |
| Q52411167 | Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. |
| Q48910476 | Fatigue in Sjogren's syndrome: relationship with fibromyalgia, clinical and biologic features. |
| Q73140775 | Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases |
| Q44583461 | Frequency of antibodies to mutated citrullinated vimentin in chronic obstructive pulmonary disease: comment on the article by Demoruelle et al. |
| Q47596764 | Frontiers of SLE: review of the 5th International Congress of Systemic Lupus Erythematosus, Cancun, Mexico, April 20-25, 1998. |
| Q38096937 | Genetics and autoantibodies |
| Q39413021 | Geographical clustering of scleroderma in a rural area in the province of Rome |
| Q72217510 | Gilbert's syndrome and chronic fatigue syndrome |
| Q40607323 | HLA-DRB1 the notorious gene in the mosaic of autoimmunity |
| Q43486994 | High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation |
| Q37361949 | Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study |
| Q35215520 | Hypovitaminosis D in recent onset rheumatoid arthritis is predictive of reduced response to treatment and increased disease activity: a 12 month follow-up study |
| Q21296720 | IL-18 Serum Level in Adult Onset Still's Disease: A Marker of Disease Activity |
| Q33239778 | Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease |
| Q40624809 | Idiopathic chronic fatigue and chronic fatigue syndrome: a comparison of two case-definitions. |
| Q44103281 | Imaging evidence of successful multiple immunosuppressive treatment of cerebral involvement in Wegener's granulomatosis. |
| Q33418883 | Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases |
| Q33491319 | Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice |
| Q38131982 | Immunogenicity of anti-tumour necrosis factor drugs in rheumatic diseases |
| Q35419865 | Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I. |
| Q69869497 | Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients |
| Q24796641 | Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate |
| Q70056760 | Increased number of CD4 cells able to bind to natural killer cell targets in the peripheral blood of AIDS related complex patients |
| Q45771331 | Increased rate of thrombin generation in hepatitis C virus cirrhotic patients. Relationship to venous thrombosis |
| Q52884535 | Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis. |
| Q37275656 | Induction of remission in rheumatoid arthritis: criteria and opportunities |
| Q37197181 | Infections and treatment of patients with rheumatic diseases. |
| Q37825062 | Inflammation as "common soil" of the multifactorial diseases |
| Q41362660 | Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo |
| Q74398609 | Interferon alpha for ocular Behçet's disease |
| Q43051359 | Interleukin 13 in synovial fluid and serum of patients with psoriatic arthritis |
| Q46513062 | Interleukin-13 (IL-13)in autoimmune rheumatic diseases: relationship with autoantibody profile. |
| Q74249536 | Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile |
| Q73378880 | Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities |
| Q73434325 | Is there a role for anti-phospholipid-binding protein antibodies in the pathogenesis of thrombosis in Behcet's disease? |
| Q51088030 | Jaccoud's arthropathy in systemic lupus erythematosus: clinical, laboratory and ultrasonographic features. |
| Q43272974 | Joint and tendineous involvement in ochronosis: clinical history and imaging of a case |
| Q42983734 | Joint sonography in asymptomatic patients with HCV correlated hepatitis |
| Q40477202 | Leishmania in SLE mimicking an exacerbation. |
| Q40188551 | Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study |
| Q37690737 | Lung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections |
| Q58421424 | Lupus anticoagulant and increased thrombin generation in patients with systemic lupus erythematosus |
| Q58421631 | Lupus anticoagulant in liver cirrhosis |
| Q51824485 | Lymph node IL-18 expression in adult-onset Still's disease. |
| Q56419697 | Magnetic resonance and ultrasonography real-time fusion imaging of the hand and wrist in osteoarthritis and rheumatoid arthritis |
| Q44774653 | Magnetic resonance imaging of peripheral osteoarticular tuberculosis compared with sonography and standard radiographs |
| Q72380807 | Magnetic resonance imaging of the parotid glands and lip biopsy in the evaluation of xerostomia in Sjögren's syndrome |
| Q45128834 | Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis |
| Q45230262 | Markers of vascular injury in Behçet's disease associated with retinal vasculitis |
| Q37111561 | Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus |
| Q73101313 | Microchimerism in Sjögren's syndrome |
| Q44021688 | Misdiagnosis in fibromyalgia: a multicentre study |
| Q44220004 | More severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis? |
| Q42228424 | Multi-functional flow cytometry analysis of CD4+ T cells as an immune biomarker for latent tuberculosis status in patients treated with tumour necrosis factor (TNF) antagonists |
| Q51754659 | Nailfold capillaroscopy abnormalities are associated with the presence of anti-endothelial cell antibodies in Sjogren's syndrome. |
| Q34213820 | Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage |
| Q37732364 | Neuroendocrine immunology of fibromyalgia |
| Q38462465 | Neuropsychiatric manifestations associated with anti-endothelial cell antibodies in systemic lupus erythematosus |
| Q60810723 | New Biological Avenues for Sjögren’s Syndrome |
| Q37872397 | New autoantigens in the antiphospholipid syndrome |
| Q36242855 | New facet of antiphospholipid antibodies |
| Q36547193 | New radiopharmaceuticals for imaging rheumatoid arthritis. |
| Q38488536 | New strategies to address the pharmacodynamics and pharmacokinetics of tumor necrosis factor (TNF) inhibitors: A systematic analysis |
| Q74116577 | No increase of serum autoantibodies during therapy with recombinant human interferon-beta1a in relapsing-remitting multiple sclerosis |
| Q58421260 | Ongoing prothrombotic state in patients with antiphospholipid antibodies: a role for increased lipid peroxidation |
| Q44676529 | Orbital myositis in a patient with primary biliary cirrhosis: successful treatment with methotrexate and corticosteroids |
| Q27000610 | Osteoarthritis of the foot: a review of the current state of knowledge |
| Q50952146 | Pain modulation in patients with fibromyalgia undergoing acupuncture treatment is associated with fluctuations in serum neuropeptide Y levels. |
| Q36666808 | Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance. |
| Q33491810 | Pathogenic natural anti-cardiolipin antibodies: the experience from monoclonal gammopathy |
| Q33493244 | Pathogenic serum IgG anticardiolipin antibodies and the idiotypic network |
| Q36758296 | Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey |
| Q37822932 | Pharmacological treatment of fibromyalgia |
| Q28645668 | Phylogeographic Refinement and Large Scale Genotyping of Human Y Chromosome Haplogroup E Provide New Insights into the Dispersal of Early Pastoralists in the African Continent |
| Q72005662 | Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis |
| Q64900234 | Plasma exchange in the treatment of acute systemic lupus erythematosus without circulating immune complexes. |
| Q73373349 | Polymorphism of the Duffy erythrocyte chemokine receptor in Italian patients with Behçet's disease |
| Q50441371 | Possible Implication of Red Blood Cells in the Prothrombotic Risk in Early Rheumatoid Arthritis. |
| Q59799935 | Potential role of platelets for atherosclerotic events in rheumatoid arthritis |
| Q35638115 | Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab |
| Q36318533 | Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models |
| Q41059860 | Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome. |
| Q54256377 | Prevalence of chronic fatigue syndrome in Italian patients with persistent fatigue. |
| Q58421416 | Prevalence of lupus anticoagulant in patients with cirrhosis: relationship with beta-2-glycoprotein I plasma levels |
| Q40616472 | Primary aspergillosis of the larynx in a patient with Felty's syndrome. |
| Q41189519 | Production of a nef-specific monoclonal antibody by the use of a synthetic peptide |
| Q40603467 | Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre study |
| Q44114238 | Protein losing enteropathy in systemic lupus erythematosus: role of diet and octreotide |
| Q48871384 | Psoriatic disease: concepts and implications |
| Q72312825 | Pulmonary arterial hypertension responsive to immunosuppressive therapy in systemic lupus erythematosus |
| Q61857006 | Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort |
| Q43440017 | Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis |
| Q37929904 | Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy |
| Q52048505 | Reconstructing the pyramid in rheumatoid arthritis. An urgent need. |
| Q72676784 | Reflex seizures as initial manifestations of systemic lupus erythematosus in childhood |
| Q73402406 | Relapsing polychondritis: a syndrome rather than a distinct clinical entity? |
| Q73378888 | Relationship of Interleukin-12 and Interleukin-13 imbalance with class-specific rheumatoid factors and anticardiolipin antibodies in systemic lupus erythematosus |
| Q50325332 | Renal parenchymal resistance in patients with biopsy proven glomerulonephritis: Correlation with histological findings. |
| Q47414862 | Reprint of "Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab". |
| Q38703626 | Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study |
| Q37385755 | Rheumatic diseases and obesity: adipocytokines as potential comorbidity biomarkers for cardiovascular diseases |
| Q51746175 | Risk factors for Sjögren's syndrome: a case-control study. |
| Q24793557 | Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement |
| Q47596696 | Role of anti-glial fibrillary acidic protein antibodies in the pathogenesis of neuropsychiatric systemic lupus erythematosus should be clarified: comment on the article by Trysberg et al. |
| Q71927253 | Saddle nose |
| Q43580784 | Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection. |
| Q73491951 | Safety profile and causes of withdrawal due to adverse events in systemic lupus erythematosus patients treated long-term with cyclosporine A |
| Q72650201 | Scleroderma and motor neuron disease: an unusual association |
| Q31079034 | Screening of a HUAEC cDNA library identifies actin as a candidate autoantigen associated with carotid atherosclerosis |
| Q24817163 | Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations |
| Q34246046 | Selective cyclooxygenase-2 inhibition: biological and clinical effects |
| Q40997117 | Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells |
| Q36167351 | Serum levels of asymmetric dimethylarginine and apelin as potential markers of vascular endothelial dysfunction in early rheumatoid arthritis |
| Q45527719 | Serum sickness associated with rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia |
| Q71808886 | Silicone breast implants and connective-tissue diseases |
| Q72841793 | Sjögren's syndrome presenting as ischemic stroke |
| Q38207763 | Sjögren's syndrome: another facet of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). |
| Q44789285 | Skin reaction associated with chrysotherapy: an unusual case |
| Q47771805 | Sleep quality in patients with primary Sjögren's syndrome |
| Q38698120 | Smoke and autoimmunity: The fire behind the disease |
| Q47596709 | Soluble CD154 plasma levels in patients with systemic lupus erythematosus: modulation by antiphospholipid antibodies |
| Q71987151 | Soluble intercellular adhesion molecule-1 in a geographical cluster of scleroderma |
| Q47779302 | Sonographic study of painful shoulder. |
| Q74028588 | Sonography in the study of metatarsalgia |
| Q58421543 | Specificity and sensitivity of diluted aPTT and anticardiolipin antibodies towards thrombosis and miscarriages in patients with systemic lupus erythematosus |
| Q73738644 | Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies |
| Q73624093 | Specificity of antinuclear and antiphospholipid antibodies in sera of patients with autoimmune lymphoproliferative disease (ALD) |
| Q28291321 | Strong intra- and inter-continental differentiation revealed by Y chromosome SNPs M269, U106 and U152 |
| Q33412737 | Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response |
| Q45281976 | Successful removal of antiphospholipid antibodies using repeated plasma exchanges and prednisone |
| Q51714523 | Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study. |
| Q36013849 | Switching tumour necrosis factor alpha antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year period |
| Q36329834 | T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy |
| Q50850816 | TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development. |
| Q34986453 | Thalidomide: focus on its employment in rheumatologic diseases |
| Q44764769 | The 6-joint ultrasonographic assessment: a valid, sensitive-to-change and feasible method for evaluating joint inflammation in RA. |
| Q90048592 | The Heart Matters: Contribution of Genetic Factors in Recurrent Pericarditis |
| Q51725688 | The Italian registry of aggressive rheumatoid arthritis -- the GIARA project. |
| Q39158831 | The Multifunctional Role of the Chemokine System in Arthritogenic Processes |
| Q58847519 | The Trypanosoma lewisi immunofluorescence test: a new simple technique for simultaneous determination of total antinuclear antibodies and the detection of antibodies to double-stranded DNA |
| Q35172149 | The clearance of apoptotic cells: implications for autoimmunity |
| Q86088651 | The hyperferritinemic syndromes and CD163: a marker of macrophage activation |
| Q36951039 | The immunology of rheumatoid arthritis |
| Q71759211 | The lactoferrin tear test in the diagnosis of Sjögren's syndrome |
| Q38241581 | The pathophysiology of anti-phospholipid antibodies. |
| Q40579193 | The role of interleukin-12 in immune-mediated rheumatic diseases |
| Q37854187 | The role of ultrasound in rheumatology |
| Q53341131 | The type I IFN system in rheumatoid arthritis. |
| Q35035562 | The vitamin D receptor agonist BXL-01-0029 as a potential new pharmacological tool for the treatment of inflammatory myopathies |
| Q39404443 | Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome |
| Q37950722 | Thromboprophylaxis in carriers of antiphospholipid antibodies (APL) without previous thrombosis: "Pros" and "Cons". |
| Q35168903 | Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis |
| Q34157602 | Treatment of thrombosis associated with immunological risk factors. |
| Q70803307 | Tricuspid valve steno-insufficiency in systemic lupus erythematosus |
| Q38200925 | Tumour necrosis factor α antagonists in the treatment of rheumatoid arthritis: an immunological perspective |
| Q71322203 | Twenty-four hour heart period variability in systemic sclerosis |
| Q41944444 | Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis |
| Q43050808 | Ultrasonographic study of painful shoulder |
| Q46530249 | Ultrasonography of salivary glands in primary Sjögren's syndrome: a comparison with contrast sialography and scintigraphy |
| Q50444480 | Ultrasound elastography assessment of skin involvement in systemic sclerosis: lights and shadows. |
| Q36500625 | Ultrasound imaging for the rheumatologist II. Ultrasonography of the hand and wrist. |
| Q36586965 | Ultrasound imaging for the rheumatologist IV. Ultrasonography of the knee. |
| Q36882085 | Ultrasound imaging for the rheumatologist IX. Ultrasound imaging in spondyloarthritis |
| Q36785134 | Ultrasound imaging for the rheumatologist VII. Ultrasound imaging in rheumatoid arthritis |
| Q36837366 | Ultrasound imaging for the rheumatologist VIII. Ultrasound imaging in osteoarthritis. |
| Q36948738 | Ultrasound imaging for the rheumatologist X. Ultrasound imaging in crystal-related arthropathies |
| Q37031629 | Ultrasound imaging for the rheumatologist XI. Ultrasound imaging in regional pain syndromes. |
| Q37049611 | Ultrasound imaging for the rheumatologist XII. Ultrasound imaging in sports medicine. |
| Q37195311 | Ultrasound imaging for the rheumatologist XIV. Ultrasound imaging in connective tissue diseases |
| Q37425298 | Ultrasound imaging for the rheumatologist XIX. Imaging modalities in rheumatoid arthritis |
| Q44983853 | Ultrasound imaging for the rheumatologist XLIV. Ultrasound of the shoulder in healthy individuals |
| Q43606462 | Ultrasound imaging for the rheumatologist XXIX. Sonographic assessment of the knee in patients with osteoarthritis |
| Q40338420 | Ultrasound imaging for the rheumatologist XXX. Sonographic assessment of the painful knee. |
| Q36422201 | Ultrasound imaging for the rheumatologist. |
| Q36701063 | Ultrasound imaging for the rheumatologist. VI. Ultrasonography of the elbow, sacroiliac, parasternal, and temporomandibular joints. |
| Q37104906 | Ultrasound imaging for the rheumatologist. XIII. New trends. Three-dimensional ultrasonography |
| Q38068637 | Ultrasound imaging for the rheumatologist. XLII. Assessment of hip pain in rheumatic patients: the radiologist's view |
| Q37199915 | Ultrasound imaging for the rheumatologist. XV. Ultrasound imaging in vasculitis |
| Q37272179 | Ultrasound imaging for the rheumatologist. XVI. Ultrasound-guided procedures. |
| Q37334504 | Ultrasound imaging for the rheumatologist. XVII. Role of colour Doppler and power Doppler. |
| Q37390897 | Ultrasound imaging for the rheumatologist. XVIII. Ultrasound measurements. |
| Q53056781 | Ultrasound imaging for the rheumatologist. XX. Sonographic assessment of hand and wrist joint involvement in rheumatoid arthritis: comparison between two- and three-dimensional ultrasonography. |
| Q37552095 | Ultrasound imaging for the rheumatologist. XXI. Role of ultrasound imaging in early arthritis. |
| Q46830992 | Ultrasound imaging for the rheumatologist. XXII. Achilles tendon involvement in spondyloarthritis. A multi-centre study using high frequency volumetric probe. |
| Q38131717 | Ultrasound in rheumatoid arthritis |
| Q38041559 | Ultrasound in the assessment of musculoskeletal involvement in systemic sclerosis |
| Q37173581 | Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs |
| Q43515114 | Use of monoclonal antibodies to identify shared idiotypes on anticardiolipin and anti-DNA antibodies in human sera. |
| Q50431231 | Uveitis with retinal occlusive vasculitis and sensorineural hypoacusia as first symptoms of relapsing polychondritis. |
| Q37242804 | Vaccination and autoimmune rheumatic diseases |
| Q82689520 | Vaccination in patients with chronic or autoimmune rheumatic diseases: the ego, the id and the superego |
| Q52880103 | Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). |
| Q42969030 | Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome |
| Q42607723 | Y chromosome microchimerism in Sjögren's syndrome. |
| Q74382201 | [About "Multiple sclerosis and autoimmune diseases" ] |
| Q67263288 | [In vitro effect of alpha-interferon and thymomodulin on natural killer activity in patients with AIDS-related complex] |
| Q74382215 | [Neurological involvement in systemic sclerosis. Evidence of a central Raynaud's phenomenon] |
| Q72271408 | [Pulmonary hypertension and systemic sclerosis] |
| Q68423648 | [Relapsing polychondritis: a case with anticartilage, anticardiolipin and anticentromere antibodies] |
| Q45016919 | [Treatment of Wegener's granulomatosis] |
| Q41666895 | sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia |
| Q61633964 | Évaluation de l’enthésite dans le rhumatisme psoriasique grâce à l’écho-Doppler énergie. Étude multicentrique |